Cargando…
PET Imaging in Animal Models of Alzheimer’s Disease
The successful development and translation of PET imaging agents targeting β-amyloid plaques and hyperphosphorylated tau tangles have allowed for in vivo detection of these hallmarks of Alzheimer’s disease (AD) antemortem. Amyloid and tau PET have been incorporated into the A/T/N scheme for AD chara...
Autores principales: | Chen, Baosheng, Marquez-Nostra, Bernadette, Belitzky, Erika, Toyonaga, Takuya, Tong, Jie, Huang, Yiyun, Cai, Zhengxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171374/ https://www.ncbi.nlm.nih.gov/pubmed/35685772 http://dx.doi.org/10.3389/fnins.2022.872509 |
Ejemplares similares
-
PET Imaging of Synaptic Density: Challenges and Opportunities of Synaptic Vesicle Glycoprotein 2A PET in Small Animal Imaging
por: Toyonaga, Takuya, et al.
Publicado: (2022) -
ImmunoPET Imaging Identifies the Optimal Timepoint for Combination Therapy in Xenograft Models of Triple-Negative Breast Cancer
por: Li, Ziqi, et al.
Publicado: (2023) -
Feasibility of imaging synaptic density in the human spinal cord using [(11)C]UCB-J PET
por: Rossano, Samantha, et al.
Publicado: (2022) -
Decreased synaptic vesicle glycoprotein 2A binding in a rodent model of familial Alzheimer's disease detected by [(18)F]SDM-16
por: Zheng, Chao, et al.
Publicado: (2023) -
Poly (ADP-ribose) polymerases as PET imaging targets for central nervous system diseases
por: Tong, Jie, et al.
Publicado: (2022)